Blockchain Registration Transaction Record

BayMedica Report Reveals Major Growth in Lesser Known Cannabinoids Market

BayMedica, a subsidiary of InMed Pharmaceuticals, releases a report on the expansion of the minor cannabinoid market in 2023, highlighting significant growth and consumer trends. The report is a testament to the evolving landscape of the cannabis industry and the increasing acceptance of cannabis use.

The report sheds light on the significant market growth of lesser known cannabinoids, driven by consumer preference for edibles with potential health benefits. This news matters as it reflects the evolving landscape of the cannabis industry and the increasing acceptance of cannabis use in society.